ea0020s16.1 | Neuroendocrine tumors | ECE2009
Oberg Kjell
Neuroendocrine tumors (NETs) constitute a rather heterogenous group of malignancies that are considered to be rare. However, resent data is indicating a significant increase in both incidence and prevalence over the last decades, with an overall incidence of 5/100 000/year and prevalence of 25/100 000/year.The treatment of NETs is based on the tumor biology (proliferation capacity and differentiation), tumor localisation and spread (TNM-staging). Surgery...